|
Market Closed -
Nasdaq
23:00:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.440 USD | -1.37% |
|
-7.69% | -82.07% |
| 10-07 | Top Midday Gainers | MT |
| 10-07 | Lipocine Inc. Through Verity Pharmaceuticals Inc Announces Health Canada Approval of Tlando for Testosterone Replacement Therapy in Adult Males | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIPOCINE INC. | Bio Therapeutic Drugs | -1.37% | -7.69% | -82.07% | -50.34% | -92.01% | 11.87M |  | | |
- Stock Market
- Stocks
- LPCN Stock
- Charts Lipocine Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
